Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, Krebs Biochemicals & Industries has informed about submission of the summary of proceedings of the 27th Annual General Meeting of the Company held on Wednesday, 27th September, 2019 at the Registered office of the Company at kothapalli (Village), Kasimkota (Mandal), Anakapalli, Vishakapatnam (District), Andhra Pradesh - 531031. Further Jhansi Laxmi, Practicing Company Secretary is the Scrutinizer for the remote e-voting and voting process carried out at the AGM through ballot paper. The results on the resolutions shall be declared by 27th September, 2019, the declared results along with scrutinizers report shall be placed on the Company’s website at www.krebsbiochem.com and on the website of Karvy at www.karvy.com and shall also be communicated to the stock Exchange where shares of the Company are listed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: